Monthly Archives: October 2018

China Reshaping the Clinical Trial Pipeline

2018-10-22T01:07:44+00:00

Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out of China.  Gone are the days of developing drugs only in the US and then watching them slowly make their way to the rest of the world. China’s current trial pipeline below illustrates a disease area focus that is on par with what we see and expect from the US, EU, and Japan.   And that’s only the beginning.  China is now taking a very active role in developing novel therapies directly, and not just for their own [...]

China Reshaping the Clinical Trial Pipeline2018-10-22T01:07:44+00:00